Therefore, the intervention composition constitutes a promising safe and effective strategy for diminishing pro-inflammatory cytokines IL-1β and TNF-α in chronic inflammatory conditions, such as overweight/pre-obesity. The gene discussed is IL1B; the disease is obesity due to melanocortin 4 receptor deficiency.